GNBT Generex Biotechnology Corp

NuGenerex Immuno-Oncology Announces Shareholder Conference Call on Thursday October 8, 2020 at 8:00 AM

NuGenerex Immuno-Oncology Announces Shareholder Conference Call on Thursday October 8, 2020 at 8:00 AM
EN
02/10/2020

Underlying

GNBTGenerex Biotechnology Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Generex Biotechnology Corp

 PRESS RELEASE
Free
GNBT Generex Biotech...

Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Ann...

Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation () (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”) to be Generex’s exclusive distributor to import, market and sell th...

July 26, 2021 1 EN
 PRESS RELEASE
Free
GNBT Generex Biotech...

NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Cl...

NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm Ii-Key Immunotherapeutic Vaccine TechnologyIi-Key-SARS-CoV-2 Vaccine Market Potential & International ContractsMarket Potential for AE37 (Ii-Key-HER2) Immunotherapeutic Vaccine for breast, prostate, and bladder cancers MIRAMAR, Fla., June 22, 2021 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO – ), a subsidiary of Generex Biotechnology Corporation () (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company with end-to-end solution...

June 22, 2021 1 EN
 PRESS RELEASE
Free
GNBT Generex Biotech...

Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside M...

Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population.Westside Medicine & Cardiology, Inc. is a professional corporation that engages medical providers who are duly licensed in Ohio to provide primary care, cardiology, and RPM services. MIRAMAR, Fla., May 11, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation () (OTCQB:GNBT) (“Generex” or the “Com...

May 11, 2021 1 EN
 PRESS RELEASE
Free
GNBT Generex Biotech...

Generex Posts Recording of May 6 Shareholder Conference Call Highlight...

Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets Update on Ii-Key-SARS-CoV-2 vaccine programAppointment of Dr. Craig Eagle to be Chairman of the Board of NuGenerex Immuno-Oncology Inc. pending board approval.Re-Launch of Excellagen® in the VA Hospital NetworkLaunch of Remote Patient Monitoring (RPM) Business NuGenHealthUpdate on Partnership & Anticipated Acquisition of AltuCell MIRAMAR, Fla., May 10, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation () (OTCQB:GNBT) (...

May 10, 2021 1 EN
 PRESS RELEASE
Free
GNBT Generex Biotech...

Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida He...

Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population.Florida Health Care Associates is a professional corporation that engages medical providers who are duly licensed in Florida to provide primary care and RPM services (/home.htm) MIRAMAR, Fla., May 06, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation () (OTCQB:GNBT) (“Generex” or the “Company”), an i...

May 6, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch